Developer docs
API playgroundTry for free, no card

Search company profiles

Clover Corporation

Full company profile

uuid000kwty

Namestring
Clover Corporation
Legal namestring
Clover Corporation Limited
Company typeenum
Public
Founded yearint
1988
Descriptiontext

Clover Corporation Limited (ASX: CLV) is an Australian B2B supplier of specialty nutritional oils and microencapsulated ingredients, headquartered in Altona North, Melbourne. The company operates through its Nu-Mega sub-brand and serves global manufacturers in four end-markets: infant and children's nutrition, senior nutrition, sports and active nutrition, and functional beverages. Its portfolio comprises 22 products built around DHA, ARA, and Choline-XL ingredients, derived principally from tuna oil.

Clover's core technology is a patented microencapsulation process that enables the stable incorporation of oxidation-sensitive omega-3 oils into dry and solid food formats such as infant formula, powdered drinks, and dietary supplements. The company is vertically integrated through a wholly owned Ecuador tuna oil facility that now supplies 30% of raw material needs, and it holds a jointly controlled interest in Melody Dairies (New Zealand) for spray drying capacity. It also claims scientific credibility through a systematic review published in Critical Reviews in Food Science and Nutrition and the support of approximately 40% of clinical trials on fish oil products via Nu-Mega, with US GRAS status for its Pre-term Emulsion.

The business model is a B2B ingredient supply model, generating revenue from bulk product sales to manufacturers under negotiated, quote-based pricing. The go-to-market combines direct enterprise sales with a distributor network covering Europe, ANZ, Southeast Asia, Japan, Korea, China, and the USA. H1 FY26 revenue reached AUD 44.1 million, up 17.3% year-over-year, with management guiding to AUD 92-96 million for full-year FY26; gross margin expanded 850 basis points to 35.6% and NPAT grew 75% to AUD 4.2 million, reflecting margin recovery and operating leverage as the Ecuador facility and specialty diversification scaled.

Short descriptiontext

Clover Corporation (ASX: CLV) is a Melbourne-based B2B supplier of DHA, ARA, and Choline-XL nutritional oils and microencapsulated ingredients. It serves global infant formula, senior nutrition, sports nutrition, and functional beverage manufacturers through its Nu-Mega sub-brand.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nutritional oils manufacturer, omega-3 ingredients supplier, microencapsulated DHA powders, infant formula ingredients, B2B nutritional ingredients
Industry4 codes
PRIMARYAFAJAKAC
Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJALAM
Lipid-Based Emulsions & Encapsulated Oils (Spray-Dried Oils, Microencapsulation)
Agriculture & Food Production/Food Ingredients & Additives/Fats & Oils Ingredients (Edible Oils, Specialty Fats, Lipid Systems)
SECONDARYAFAJACAL
Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation)
Agriculture & Food Production/Food Ingredients & Additives/Emulsifiers & Stabilizers (Lecithin, Mono/Diglycerides, Stabilizer Systems)
SECONDARYCRADAEAI
Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins)
NAICS code2 codes
  • Fats and Oils Refining and Blending311225
  • Starch and Vegetable Fats and Oils Manufacturing31122
SIC code2 codes
  • Fats & Oils2070
  • Medicinal Chemicals & Botanical Products2833
Product category
Nutritional Oils and Microencapsulated Ingredients
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Nutritional Ingredients Product Sales
TypeOne Time License
Description

Clover generates revenue primarily through the sale of nutritional oils (DHA, ARA) and microencapsulated powder ingredients to manufacturers in the infant nutrition, senior nutrition, powdered drinks, and sports nutrition markets. Revenue is derived from a portfolio of 22 products with strategic diversification into higher-margin specialty categories driving margin expansion.

seekingalpha.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Operations, Personnel, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Nu-Mega
Description

Science-based bioactives brand delivering benefits to global infant, children and medical food markets.

clovercorp.com.au
+1 more record
Core offering1 text field

Clover Corporation manufactures and supplies nutritional oils and microencapsulated powder ingredients — principally DHA, ARA and Choline-XL — to infant formula, senior nutrition, sports nutrition and powdered drinks manufacturers worldwide. The portfolio of 22 products is enabled by the company's patented microencapsulation technology, which protects omega-3 oils from oxidation and enables stable delivery in dry and solid food formats, with raw material supplied in part by its company-owned Ecuador tuna oil facility.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Clover Corporation operates primarily through its Nu-Mega sub-brand, offering a portfolio of nutritional oil ingredients and microencapsulation technology services. The company supplies DHA oils and DHA powders to the global infant, children, and medical food markets. Their core offerings center on Omega-3 fatty acids extracted from tuna, with proprietary microencapsulation technology enabling commercial delivery. The portfolio includes 22 products spanning infant formula, seniors nutrition, powdered drinks, and sports nutrition segments. A new product initiative called Premneo was recently introduced.

Product and service6 records
1Nu-Mega Nutritional Ingredient Brand
CategoryCommercial ingredient brand / nutritional oils portfolio
Description

Clover's commercial business brand offering a portfolio of nutritional oils (DHA, ARA) and microencapsulated powder ingredients serving global infant, children and medical food manufacturers with science-based bioactives.

2DHA Oils
CategoryNutritional oil ingredient
Description

Fish oil products containing high levels of omega-3 fatty acids, including DHA, supplied to nutritional product manufacturers for use in infant formula, senior nutrition and sports nutrition applications.

3DHA Powders
CategoryMicroencapsulated powder ingredient
Description

Powdered formulations of DHA produced via Clover's patented microencapsulation technology for use in food, beverage, and nutritional supplement applications.

4ARA (Arachidonic Acid)
CategoryNutritional oil ingredient
Description

Nutritional oil ingredient supplied for use in infant formula and pediatric nutritional applications, providing the omega-6 fatty acid arachidonic acid.

5Choline-XL
CategorySpecialty nutritional ingredient
Description

Specialty ingredient included in Clover's higher-margin product diversification strategy, supplied for use in nutritional formulations targeting brain and cognitive development.

6Premneo
CategoryNew product initiative / sub-brand
Description

New product line/brand within Clover's portfolio, with a dedicated product website (premneo.com). Specific product offerings under the Premneo brand had not yet been disclosed at the time of the source.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Melody Dairies
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-11-05
Description

Clover invested in Melody Dairies in New Zealand, adding spray drying capacity to its operations. The facility is now operating profitably following resolution of covenant issues, contributing to improved manufacturing performance and operational efficiency.

seekingalpha.com
Strategic tierCoreTypeOthers
Description

Nu-Mega is Clover's commercial business unit, internationally recognized for collaboration with research institutions to scientifically validate the benefits of high DHA fish oil consumption. Nu-Mega has supported 40% of clinical trials on human and animals with fish oil products.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global nutrition and health ingredients leader with a broad omega-3 (including DHA from algae and fish), ARA, and nutritional lipids portfolio serving infant formula, dietary supplements, and functional food manufacturers — directly overlapping with Clover's core product set but at vastly greater scale.

TypeBroad incumbent
Description

Diversified chemical and nutrition company supplying omega-3 fatty acids (including DHA oils) and other nutritional lipids to infant formula and functional food manufacturers globally; competes with Clover on ingredient supply but with a much broader portfolio.

TypeBroad incumbent
Description

Specialty chemicals and consumer care ingredients supplier with a focused nutritional lipids business (including high-purity omega-3 concentrates) serving infant nutrition, dietary supplements, and personal care; comparable to Clover as a B2B nutritional lipid specialist at larger scale.

TypeDirect peer
Description

Norwegian krill-based omega-3 (EPA/DHA) ingredient supplier with Superba krill oil and similar encapsulated and oil products targeting human nutrition, including infant, sports, and senior nutrition — a direct peer in the marine-sourced omega-3 ingredients market.

TypeDirect peer
Description

Specialist in high-concentration omega-3 EPA/DHA oils and encapsulated powders serving nutritional supplement and infant formula manufacturers globally; competes with Clover in encapsulated omega-3 ingredient supply.

TypeDirect peer
Description

Norwegian-based fish oil refiner producing refined EPA/DHA oils and specialty marine lipid ingredients for human nutrition, including infant formula; comparable to Clover's DHA oil and microencapsulated ingredient offering.

TypeDirect peer
Description

Producer of high-concentration omega-3 EPA/DHA oils and encapsulated ingredients for nutraceutical and infant formula markets; directly comparable to Clover's refined DHA and microencapsulated powder portfolio.

TypeDirect peer
Description

Canadian supplier of omega-3 oils (including DHA-rich fish oils) and microencapsulated powders for the nutritional supplement, food, and beverage industries; closely comparable to Clover's ingredient and encapsulation offering.

9Royal DSM (now dsm-firmenich) Algae DHA supplier via Martek
TypeDirect peer
Description

Through its Martek heritage, dsm-firmenich supplies life'sDHA from algae — a competing DHA source used in infant formula alongside fish-oil-derived DHA, making it a direct substitute competitor in Clover's primary segment.

TypeRegional player
Description

US-headquartered specialty chemical and nutritional ingredient manufacturer with omega-3 lipid products serving the North American nutrition market; relevant peer given Clover's USA expansion, though with a primarily North American geographic focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clover Corporation

Nutritional Oils and Microencapsulated Ingredientsclovercorp.com.au

Clover Corporation (ASX: CLV) is a Melbourne-based B2B supplier of DHA, ARA, and Choline-XL nutritional oils and microencapsulated ingredients. It serves global infant formula, senior nutrition, sports nutrition, and functional beverage manufacturers through its Nu-Mega sub-brand.

What Clover Corporation does

Clover Corporation Limited (ASX: CLV) is an Australian B2B supplier of specialty nutritional oils and microencapsulated ingredients, headquartered in Altona North, Melbourne. The company operates through its Nu-Mega sub-brand and serves global manufacturers in four end-markets: infant and children's nutrition, senior nutrition, sports and active nutrition, and functional beverages. Its portfolio comprises 22 products built around DHA, ARA, and Choline-XL ingredients, derived principally from tuna oil.

Clover's core technology is a patented microencapsulation process that enables the stable incorporation of oxidation-sensitive omega-3 oils into dry and solid food formats such as infant formula, powdered drinks, and dietary supplements. The company is vertically integrated through a wholly owned Ecuador tuna oil facility that now supplies 30% of raw material needs, and it holds a jointly controlled interest in Melody Dairies (New Zealand) for spray drying capacity. It also claims scientific credibility through a systematic review published in Critical Reviews in Food Science and Nutrition and the support of approximately 40% of clinical trials on fish oil products via Nu-Mega, with US GRAS status for its Pre-term Emulsion.

The business model is a B2B ingredient supply model, generating revenue from bulk product sales to manufacturers under negotiated, quote-based pricing. The go-to-market combines direct enterprise sales with a distributor network covering Europe, ANZ, Southeast Asia, Japan, Korea, China, and the USA. H1 FY26 revenue reached AUD 44.1 million, up 17.3% year-over-year, with management guiding to AUD 92-96 million for full-year FY26; gross margin expanded 850 basis points to 35.6% and NPAT grew 75% to AUD 4.2 million, reflecting margin recovery and operating leverage as the Ecuador facility and specialty diversification scaled.

Clover Corporation firmographics

Firmographics
Name
Clover Corporation
Legal name
Clover Corporation Limited
Website
https://clovercorp.com.au
Company type
Public
Founded year
1988
Operating status
Operating
Headcount range
11–50 employees
Short description
Clover Corporation (ASX: CLV) is a Melbourne-based B2B supplier of DHA, ARA, and Choline-XL nutritional oils and microencapsulated ingredients. It serves global infant formula, senior nutrition, sports nutrition, and functional beverage manufacturers through its Nu-Mega sub-brand.
Ownership category
akta.pro rank

Clover Corporation industry classification

Industry
Product category
Nutritional Oils and Microencapsulated Ingredients
NAICS
Fats and Oils Refining and Blending (311225), Starch and Vegetable Fats and Oils Manufacturing (31122)
SIC
Fats & Oils (2070), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYAFAJAKAC
Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYAFAJALAM
Lipid-Based Emulsions & Encapsulated Oils (Spray-Dried Oils, Microencapsulation)
Agriculture & Food Production/Food Ingredients & Additives/Fats & Oils Ingredients (Edible Oils, Specialty Fats, Lipid Systems)
SECONDARYAFAJACAL
Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation)
Agriculture & Food Production/Food Ingredients & Additives/Emulsifiers & Stabilizers (Lecithin, Mono/Diglycerides, Stabilizer Systems)
SECONDARYCRADAEAI
Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins)

Keywords

  • Nutritional oils manufacturer
  • Omega-3 ingredients supplier
  • Microencapsulated DHA powders
  • Infant formula ingredients
  • B2B nutritional ingredients

Where Clover Corporation is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices4 records

Markets served

Clover Corporation business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

  1. Nutritional Ingredients Product Sales: Clover generates revenue primarily through the sale of nutritional oils (DHA, ARA) and microencapsulated powder ingredients to manufacturers in the infant nutrition, senior nutrition, powdered drinks, and sports nutrition markets. Revenue is derived from a portfolio of 22 products with strategic diversification into higher-margin specialty categories driving margin expansion.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Clover Corporation product offering

Product offering

Core offering

Clover Corporation manufactures and supplies nutritional oils and microencapsulated powder ingredients — principally DHA, ARA and Choline-XL — to infant formula, senior nutrition, sports nutrition and powdered drinks manufacturers worldwide. The portfolio of 22 products is enabled by the company's patented microencapsulation technology, which protects omega-3 oils from oxidation and enables stable delivery in dry and solid food formats, with raw material supplied in part by its company-owned Ecuador tuna oil facility.

Product overview

Clover Corporation operates primarily through its Nu-Mega sub-brand, offering a portfolio of nutritional oil ingredients and microencapsulation technology services. The company supplies DHA oils and DHA powders to the global infant, children, and medical food markets. Their core offerings center on Omega-3 fatty acids extracted from tuna, with proprietary microencapsulation technology enabling commercial delivery. The portfolio includes 22 products spanning infant formula, seniors nutrition, powdered drinks, and sports nutrition segments. A new product initiative called Premneo was recently introduced.

Differentiator

Problem solved

Functional benefit

Brands

  • Nu-Mega: Science-based bioactives brand delivering benefits to global infant, children and medical food markets.
  • Premneo

Products and services

  • Nu-Mega Nutritional Ingredient Brand Clover's commercial business brand offering a portfolio of nutritional oils (DHA, ARA) and microencapsulated powder ingredients serving global infant, children and medical food manufacturers with science-based bioactives.
  • DHA Oils Fish oil products containing high levels of omega-3 fatty acids, including DHA, supplied to nutritional product manufacturers for use in infant formula, senior nutrition and sports nutrition applications.
  • DHA Powders Powdered formulations of DHA produced via Clover's patented microencapsulation technology for use in food, beverage, and nutritional supplement applications.
  • ARA (Arachidonic Acid) Nutritional oil ingredient supplied for use in infant formula and pediatric nutritional applications, providing the omega-6 fatty acid arachidonic acid.
  • Choline-XL Specialty ingredient included in Clover's higher-margin product diversification strategy, supplied for use in nutritional formulations targeting brain and cognitive development.
  • Premneo New product line/brand within Clover's portfolio, with a dedicated product website (premneo.com). Specific product offerings under the Premneo brand had not yet been disclosed at the time of the source.

Companies that use Clover Corporation

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Clover Corporation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Clover Corporation partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Melody DairiescoreStrategic or Co-development Partner · 5 November 2018Clover invested in Melody Dairies in New Zealand, adding spray drying capacity to its operations. The facility is now operating profitably following resolution of covenant issues, contributing to improved manufacturing performance and operational efficiency.
  • Nu-Mega IngredientscoreOthersNu-Mega is Clover's commercial business unit, internationally recognized for collaboration with research institutions to scientifically validate the benefits of high DHA fish oil consumption. Nu-Mega has supported 40% of clinical trials on human and animals with fish oil products.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Clover Corporation competitors and assessment

Company assessment

Broad incumbents

  • dsm-firmenich: Global nutrition and health ingredients leader with a broad omega-3 (including DHA from algae and fish), ARA, and nutritional lipids portfolio serving infant formula, dietary supplements, and functional food manufacturers — directly overlapping with Clover's core product set but at vastly greater scale.
  • BASF SE: Diversified chemical and nutrition company supplying omega-3 fatty acids (including DHA oils) and other nutritional lipids to infant formula and functional food manufacturers globally; competes with Clover on ingredient supply but with a much broader portfolio.
  • Croda International: Specialty chemicals and consumer care ingredients supplier with a focused nutritional lipids business (including high-purity omega-3 concentrates) serving infant nutrition, dietary supplements, and personal care; comparable to Clover as a B2B nutritional lipid specialist at larger scale.

Direct peers

  • Aker BioMarine: Norwegian krill-based omega-3 (EPA/DHA) ingredient supplier with Superba krill oil and similar encapsulated and oil products targeting human nutrition, including infant, sports, and senior nutrition — a direct peer in the marine-sourced omega-3 ingredients market.
  • KD Pharma Group: Specialist in high-concentration omega-3 EPA/DHA oils and encapsulated powders serving nutritional supplement and infant formula manufacturers globally; competes with Clover in encapsulated omega-3 ingredient supply.
  • GC Rieber Oils: Norwegian-based fish oil refiner producing refined EPA/DHA oils and specialty marine lipid ingredients for human nutrition, including infant formula; comparable to Clover's DHA oil and microencapsulated ingredient offering.
  • Epax (Pelagia): Producer of high-concentration omega-3 EPA/DHA oils and encapsulated ingredients for nutraceutical and infant formula markets; directly comparable to Clover's refined DHA and microencapsulated powder portfolio.
  • Bioriginal Food & Science Corp. Canadian supplier of omega-3 oils (including DHA-rich fish oils) and microencapsulated powders for the nutritional supplement, food, and beverage industries; closely comparable to Clover's ingredient and encapsulation offering.
  • Royal DSM (now dsm-firmenich) Algae DHA supplier via Martek: Through its Martek heritage, dsm-firmenich supplies life'sDHA from algae — a competing DHA source used in infant formula alongside fish-oil-derived DHA, making it a direct substitute competitor in Clover's primary segment.

Regional players

  • Stepan Company: US-headquartered specialty chemical and nutritional ingredient manufacturer with omega-3 lipid products serving the North American nutrition market; relevant peer given Clover's USA expansion, though with a primarily North American geographic focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Clover Corporation social profiles

Digital presence

Clover Corporation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clover Corporation leadership team

Management profile

Number of profiles

Profiles11 records

Clover Corporation subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Clover Corporation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clover Corporation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clover Corporation

What does Clover Corporation do?

Clover Corporation manufactures and supplies nutritional oils and microencapsulated powder ingredients — principally DHA, ARA and Choline-XL — to infant formula, senior nutrition, sports nutrition and powdered drinks manufacturers worldwide. The portfolio of 22 products is enabled by the company's patented microencapsulation technology, which protects omega-3 oils from oxidation and enables stable delivery in dry and solid food formats, with raw material supplied in part by its company-owned Ecuador tuna oil facility.

Is Clover Corporation a public or private company?

Clover Corporation is a public company. It is classified as public and is currently operating.

When was Clover Corporation founded?

Clover Corporation was founded in 1988. It employs 11 to 50 people.

Where is Clover Corporation based?

Clover Corporation is headquartered in Melbourne, Australia, in the Oceania region.

How does Clover Corporation make money?

One revenue line is on record: nutritional Ingredients Product Sales.

Who are Clover Corporation's main competitors?

Broad incumbents on record are dsm-firmenich, BASF SE and Croda International. Direct peers are Aker BioMarine, KD Pharma Group, GC Rieber Oils, Epax (Pelagia), Bioriginal Food & Science Corp. and Royal DSM (now dsm-firmenich) Algae DHA supplier via Martek. Stepan Company is listed as a regional player.

Does Clover Corporation have an API?

No public API is recorded for Clover Corporation.

What industry is Clover Corporation in?

Clover Corporation's product category is Nutritional Oils and Microencapsulated Ingredients. Its primary akta.pro industry code is AFAJAKAC, Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids), with a secondary code of AFAJALAM, Lipid-Based Emulsions & Encapsulated Oils (Spray-Dried Oils, Microencapsulation). Its NAICS code is 311225 and its SIC code is 2070.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comClover FY26 slides: margins surge to 35.5% as new products dominate By Investing.comClover Corporation reported FY26 revenue of $97.4 million, up 13% year-over-year, and net profit after tax of $10.5 million, a 50% increase. Gross margin expanded to 35.5% as new products, which now account for 64% of revenue, drove profitability. The company also eliminated all interest-bearing debt and declared a final dividend of 1.25 cents per share.Investing.comClover FY26 slides: margins surge to 35.5% as new products dominate By Investing.comClover Corporation reported FY26 revenue of $97.4 million, up 13% year-over-year, and net profit after tax of $10.5 million, a 50% increase. Gross margin expanded to 35.5% as new products, now 64% of revenue, drove profitability. The company eliminated all interest-bearing debt and declared a final dividend of 1.25 cents per share.Investing.comClover FY26 slides: revenue tops guidance as margins hit 35.5% By Investing.comClover Corporation reported FY26 revenue of $97.4 million, beating guidance, and net profit after tax of $10.5 million, up 50%. Gross margin expanded to 35.5% from 30.5%, driven by a product mix shift toward higher-margin new products. The company plans to enter the U.S. nutraceutical market and expects FY27 revenue ahead of the prior period.Investing.comClover FY26 slides: revenue tops guidance as margins hit 35.5% By Investing.comClover Corporation reported FY26 revenue of $97.4 million, beating guidance, and net profit after tax of $10.5 million, up 50%. Gross margin expanded to 35.5% from 30.5%, driven by a product mix shift toward higher-margin new products. The company plans to enter the U.S. nutraceutical market and expects FY27 revenue ahead of the prior period.Investing.comEarnings call transcript: Clover posts record H2 2026 as margins widen By Investing.comClover Corporation reported record FY2026 revenue of AUD 97.4 million, up 13% and above guidance, with net profit after tax rising 50% to AUD 10.5 million. Gross margin improved to 35.5%, and ARA products drove growth, while management expects continued expansion in FY2027.Seeking AlphaClover Corporation Limited (CLVCF) Q2 2026 Earnings Call TranscriptClover Corporation Limited reported record first half FY26 results with revenue up $6.5 million to $44.1 million, EBITDA of $6.9 million (up $2.6 million), and NPAT of $4.2 million (up $1.8 million), driven by new customer acquisition, improved product mix, and better manufacturing performance across its portfolio of 22 products. The company declared a $0.01 per share interim fully franked dividend, fully repaid its bank debt, and raised full-year revenue guidance to $92-96 million, citing strong demand across infant formula, seniors nutrition, powdered drinks, and sports nutrition segments. Key operational highlights include its Ecuador tuna oil facility now supplying 30% of raw material needs and Melody Dairies in New Zealand operating profitably following resolution of covenant issues.Investing.comClover 1H FY26 slides: margins surge as new products fuel growth By Investing.comClover Corporation Limited reported strong first-half fiscal 2026 results on March 23, 2026, with revenue rising 17.3% year-over-year to $44.1 million and net profit surging 75% to $4.2 million, driven by strategic product diversification into higher-margin categories. The company's gross margin expanded by 850 basis points to 35.6%, reflecting its shift away from traditional infant formula toward senior nutrition and powdered drinks, while its stock price jumped 18.12% to $0.745. Management provided optimistic full-year guidance of $92-96 million in revenue, though the outlook includes a caveat about geopolitical tensions and supply chain stability.Investing.comEarnings call transcript: Clover Corporation’s Q1 2026 sees record revenue By Investing.comClover Corporation Limited reported record first-half fiscal year 2026 revenue of AUD 44.1 million, up 17.3% year-on-year, with net profit after tax surging 75% to AUD 4.2 million and gross margin expanding to 35.6% from 30.4%. The company repaid all bank debt, declared a fully franked interim dividend of AUD 0.01 per share, and provided full-year revenue guidance of AUD 92–96 million, which would represent a record year. The strong performance was driven by a strategic shift toward higher-margin specialty products, new customer acquisitions, a distributor-based model expansion, and contributions from the company-owned Ecuador tuna oil facility and its Melody Dairies investment in New Zealand.TradingViewClover Corporation Posts Strong 1H FY26 Results with Maintained FY26 GuidanceClover Corporation reported H1 FY26 revenue of $44.1m, a 17% increase from the prior year period, driven by recovery across Europe and ANZ alongside key customer growth. Gross margin significantly improved to 35.6% from 27.1%, an 850 basis point expansion attributed to favorable product mix and strong manufacturing performance. The company maintained its full-year FY26 revenue guidance of $92m to $96m, expecting positive momentum to continue into a stronger second half.TipranksClover Distances Itself from ARA Oil Contamination Behind Infant Formula RecallsClover Corporation Limited, an Australian ASX-listed nutritional oils supplier, issued a market announcement clarifying that its infant formula products are not implicated in recent recalls tied to ARA (Arachidonic Acid) oil contamination from a separate, unrelated third-party supplier. The company states that routine quality controls and additional targeted testing confirm its products remain safe, fully compliant and uninterrupted. Clover is actively engaging with customers on alternative formulations and supply continuity as a show of reliability amid broader sector disruption.